Hinge Health files for an IPO, aiming for a NYSE listing under 'HNGE' as revenue jumps 33% to $390M in 2024 and net losses narrow significantly.
A wave of companies are offering potential solutions that won’t cut the chemicals out of the supply chain but destroy them.
After scrapping plans for an IPO in 2022, Hinge Health Inc. is taking a more favorable view of going public given the increased support seen for health care and med-tech stocks in recent months. The ...